Ann Miller
Director/Board Member bij INOVIO PHARMACEUTICALS, INC.
Vermogen: 76 951 $ op 31-03-2024
Actieve functies van Ann Miller
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Director/Board Member | 25-03-2019 | - |
| Independent Dir/Board Member | 25-03-2019 | - | |
| ALLENA PHARMACEUTICALS, INC. | Director/Board Member | 05-10-2020 | - |
| Independent Dir/Board Member | 05-10-2020 | - |
Loopbaan van Ann Miller
Eerdere bekende functies van Ann Miller
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Director/Board Member | 01-10-2019 | 31-12-2021 |
| Independent Dir/Board Member | 01-10-2019 | 31-12-2021 | |
| Sanofi SA | Sales & Marketing | 01-01-2012 | 01-09-2018 |
| EISAI CO., LTD. | Corporate Officer/Principal | 01-01-2009 | 01-01-2011 |
| AMGEN INC. | Sales & Marketing | 01-01-2002 | 01-01-2007 |
Opleiding van Ann Miller
| Duke University | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Japan | 2 |
| Frankrijk | 2 |
Operationeel
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
| Sales & Marketing | 2 |
Sectoraal
| Health Technology | 7 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| EISAI CO., LTD. | Health Technology |
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| ALLENA PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
| Sanofi SA | Health Technology |
- Beurs
- Insiders
- Ann Miller
- Ervaring
